Editorial Commentary: Where to Place the New Treatments for Clostridium difficile Infection?

Clin Infect Dis. 2016 Sep 15;63(6):735-6. doi: 10.1093/cid/ciw366. Epub 2016 Jun 30.

¹ Department I of Internal Medicine and Center for Integrated Oncology CIO Köln/Bonn, University Hospital of Cologne German Centre for Infection Research, Partner Site Bonn-Cologne Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases, and Clinical Trials Center Cologne, ZKS Köln, University of Cologne, Germany.
² Department I of Internal Medicine and Center for Integrated Oncology CIO Köln/Bonn, University Hospital of Cologne German Centre for Infection Research, Partner Site Bonn-Cologne.

No abstract available

Keywords: Clostridium difficile; bezlotoxumab; fidaxomicin; recurrence; treatment pathway.

Publication types